INTRODUCTION
Autophagy is a multistep catabolic process that occurs during nutrient deprivation, metabolic stresses, tumor growth, normal mammalian development and differentiation (Degenhardt et al., 2006 , Mizushima & Levine, 2010 . It begins with the formation of double-membrane vesicles, autophagosomes, which engulf cytoplasmic constituents. The autophagosomes fuse with lysosomes, where the damaged or long-lived proteins and organelles are degraded and recycled as a protective mechanism and adaptive response to stressful conditions (Degenhardt et al., 2006) . Excessive and sustained activation of autophagy, however, seems to provoke cell demise (autophagic cell death) by depleting cell organelles and critical proteins. Consistent with its function to either induce cell death or promote cell survival, several lines of evidence suggest the paradoxical role of autophagy in cancer cells induced by a variety of anti-cancer drugs, with response enhancing or counteracting their anticancer effect (Degenhardt et al., 2006) . Chloroquine (CQ) is one of lysosomotropic agents as a weak basic amine. It can freely diffuse across lysosomal membranes in uncharged form but can also become protonated and trapped within acidic vesicles such as lysosomes. The protonation of CQ results in inhibition of hydrolytic lysosomal enzymes by perturbing the acidic milieu (pH<5) of lysosome, which has made CQ an useful drug in the treatment of malaria (Kroemer & Jaattela, 2005) . CQ can suppress autophagy by accumulating in the lysosomal lumen and inhibiting the autophagolysosome formation (Boya & Kroemer, 2008) . Since several current studies have revealed that tumor resistance to anticancer therapies including radiation therapy, chemotherapy and molecular targeted therapies is attributed to upregulation of autophagy as a protective mechanism (Hu et al., 2012; Zou et al., 2012) , CQ and its derivative hyroxychloroquine have been used as an autophagy inhibitor available for clinical trials of cancer patients. In addition, inhibition of autophagy by CQ synergistically augments cytotoxicity in combination with several anticancer drugs in preclinical models (Takeuchi et al., 2005; Syelo et al., 2006; Carew et al., 2007; Xu et al., 2011; Firat et al., 2012) . Recently, however, evidence has been accumulated suggesting that the ability of CQ to inhibit autophagy by blocking autophagolysosome formation may not be the only mechanism by which it exerts antitumor effect. Lysosomotropic CQ sensitizes breast cancer cells to chemotherapy independent of autophagy since autophagy blockage by knocking out autophagy gene such as Atg12 and Beclin 1, or bafilomycin A1 treatment did not show any sensitization effect to chemotherapy (Maycotte et al., 2012) . Another report also showed that PI3K/mTOR inhibitor PI103 enhances the lysosomal compartment by increasing its size and function, while CQ destabilizes lysosomal membranes (Enzenmuller et al., 2013) . When the accumulation of protonated CQ within lysosomes reaches above a certain threshold, it attains the detergentlike activity and leads to lysosomal membrane permeabilization (LMP) (Boya & Kroemer, 2008) . LMP releases the cathepsins and other hydrolytic enzymes from lysosomal lumen into the cytosol, which can result in apoptosis with mitochondrial outer membrane permeabilization and caspases activation, or in necrosis depending on the extent of LMP and the cell context (Kroemer & Jaattela, 2005; Boya & Kroemer, 2008) .
Thus the present study was undertaken to demonstrate the properties and underlying mechanism for the dual activities of CQ, autophagy inhibitor or LMP inducer, by using human colorectal cancer cell line HCT15.
MATERIALS & METHODS

Cell culture and reagents
The human colorectal cancer cell line HCT15 was obtained from the American Type Culture Collection (Manassas, VA). Cells were grown in a monolayer culture in DMEM (Sigma) supplemented with 10% fetal bovine serum (Sigma) and 1% streptomycin/penicillin, and were maintained at 
Cell viability assay
To determine the effects of CQ and/or NVP-BEZ235 on HCT15 cell viability after the treatments, we used MTT assay as described previously (Song et al., 2011) . Cells were harvested and seeded at 4 × 10 4 cells per well (0.5 mL) in 24-well plates and incubated overnight at 37 o C.
The cells were then incubated for 48 hours with CQ and/or NVP-BEZ235, or for 12, 24, 48, and 72 hours with CQ to determine the dose-and time-dependent cell survival rate.
Then the cells were incubated with MTT reagent for 3 hours at 37 o C, followed by solubilization of the formazan crystal with propanol for 30 minutes. Absorbance was measured at 570 nm with a microplate analyzer. All the experiments were performed in triplicate. 
Statistical analysis
Data were expressed in the form of mean ± SEM. The statistical analysis was done using Student's t Test. Differences between means were considered as significant when yielding p < 0.05.
RESULTS
Effects of CQ on the cell viability of colorectal cancer cells
To test the effect of CQ on the survival of colorectal cancer cells, we treated HCT15 cell line harboring PI3K
and K-Ras mutation with CQ at concentrations of 5 uM to 80 uM for 12, 24, 48, or 72 hours and then antiproliferative activity of CQ was measured by using MTT assay. As shown in Fig. 1 , CQ inhibited cell viability in dose-and time-dependent manners in the range of CQ concentration between 20 to 80 uM, whereas it did not show antiproliferative activity at 5 and 10 uM.
CQ shows differential effects on colorectal cancer cells in a concentration-dependent fashion
There has been some conflicting results and interpretation Error bars, SEM.
about the effects of CQ treatment on cancer cells, which seem to be due to the varied concentrations of CQ treated (Xu et al., 2011; Seitz et al., 2013) . CQ is not only an autophagy inhibitor by blocking the fusion of autophagosome and lysosome in the late stage of autophagy, but it can lead to cell death since the protonated form of CQ reaching above a certain threshold acquires detergent-like properties, which results in lethal lysosomal destabilization known as LMP (Boya & Kroemer, 2008) . Therefore, we hypothesized that CQ may act as an autophagy inhibitor at a low concentration, but as an LMP inducer at a high concentration above the threshold attaining detergent-like activity. To prove this, we employed HCT15 cell line, since our unpublished study showed that autophagy inhibition by CQ rescued the HCT15 cell viability in cotreatment regimen with anticancer drug NVP-BEZ235 (BEZ235) of a dual inhibitor of PI3K
and mTOR (Maira et al., 2008) . As revealed in Fig 
CQ induces production of ROS and antioxidants increase cell viability
Since reactive oxygen species (ROS) can regulate the induction of autophagy and LMP (Terman & Kurz, 2006; Scherz-Schouval et al., 2007) , we investigated whether ROS is generated in response to the high concentration of CQ treatment and whether ROS production contributes to the cell viability. We used the general ROS scavenger N-acetylcysteine (NAC), a precursor of the antioxidant glutathione that has antioxidant effects via its thiol group (Zafarullah et al., 2006) , and trolox, a derivative of the antioxidant vitamine E (Seifried et al., 2003) . At high concentrations of CQ, both NAC and trolox resulted in the rescue of cell viability (Fig. 3A) . We next analyzed the generation of ROS upon treatment of CQ using the Image-iT Live green ROS detection kit. Increased cellular ROS were detected following high concentration of CQ treatment, but the low concentration of CQ treatment showed little ROS positive signal (Fig. 3B) .
DISCUSSION
The present study, using human colon cancer cell line 
